The effect of immune function changes by glycemic control with (STG-55) artificial pancreas during heart surgery

The effect of immune function changes by glycemic control with (STG-55) artificial pancreas during heart surgery - The effect of immune function changesby glycemic control with artificial pancreas

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012614

Enrollment

Registered

2013-12-18

Start date

2012-11-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart diseases

Interventions

artificial pancrease control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: heart diseases

Exclusion criteria

Exclusion criteria: beyond HbA1c(NGSP) 7.4, CKD stage 4

Design outcomes

Primary

Measure	Time frame
CL value	—

Secondary

Measure	Time frame
IL-6,10,blood glucose level	—

Countries

Japan

Contacts

Public ContactMasanori Tsukamoto

Kyushu University Department of Dental Anesthesiology

tsukamoto@dent.kyushu-u.ac.jp+81926426480

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026